Dis-Chem Pharmacies (DCPJ)

Currency in ZAR
3,135
-19(-0.60%)
Closed·

DCPJ Financial Summary

Key Ratios

P/E Ratio23.99
Price/Book5.42
Debt / Equity119.25%
Return on Equity25.13%
Dividend Yield1.75%
EBITDA2.54B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
29/02
2017
28/02
2018
28/02
2019
28/02
2020
29/02
2021
28/02
2022
28/02
2023
28/02
2024
29/02
2025
28/02
* In Millions of ZAR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.38%
Dividend Yield
1.75%
Industry Median 3.98%
Annualised payout
54.83
Paid annually
5-Years Growth
+33.79%
Growth Streak

Analyst Ratings

4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3,964
(+26.44% Upside)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.70 / 64.60
Revenue / Forecast
19.61B / --
EPS Revisions
Last 90 days

FAQ

What were Dis-Chem Pharmacies's earnings for the latest quarter?

The Dis-Chem Pharmacies EPS (TTM) is 1.38. Dis-Chem Pharmacies reported sales of 19,609.74, net income of 602.10, and EPS of 0.70 for the latest quarter.

What was Dis-Chem Pharmacies's net income for the latest quarter?

Dis-Chem Pharmacies's net income for the latest quarter was 602.10.

How did Dis-Chem Pharmacies's performance compare year-over-year in the latest quarter?

The company's revenue moved from 19,562.60 in the previous quarter to 19,609.74 in the latest quarter, and net income moved from 577.71 to 602.10 compared to the previous quarter.

What is Dis-Chem Pharmacies's net profit margin on a TTM basis?

Dis-Chem Pharmacies's trailing twelve months (TTM) net profit margin is 3.01%.

How does Dis-Chem Pharmacies's debt to equity ratio compare to industry standards?

Dis-Chem Pharmacies's total debt-to-equity ratio is 119.25%.

What is Dis-Chem Pharmacies's return on investment on a TTM basis?

Dis-Chem Pharmacies's trailing twelve months (TTM) return on investment (ROI) is 25.13%.

Did Dis-Chem Pharmacies gain or lose cash last quarter?

In the latest quarter, Dis-Chem Pharmacies's net change in cash was -894.35 million.

What were Dis-Chem Pharmacies's total assets and liabilities in the latest quarter?

As of the latest quarter, Dis-Chem Pharmacies reported total assets of 19,256.94 million and total liabilities of 10,177.82 million.

How has Dis-Chem Pharmacies's total revenue grown this year?

Dis-Chem Pharmacies's total revenue was 19,562.60 in the previous quarter and 19,609.74 in the latest quarter.

What is Dis-Chem Pharmacies's gross margin on a TTM basis?

Dis-Chem Pharmacies's trailing twelve months (TTM) gross margin is 22.47%.

What was Dis-Chem Pharmacies's revenue per share for the latest quarter?

Dis-Chem Pharmacies's revenue per share for the latest quarter was 441.24.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.